Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension and Hyperhomocysteinemia ：a Double-blind Randomized Controlled Trial

NCT01848873 is registered in ClinicalTrials.gov with Shenzhen Ausa Pharmed Co.,Ltd as lead sponsor.

NCT NCT01848873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01848873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine in Patients With Mild to Moderate Hypertension and Hyperhomocysteinemia ：a Double-blind Randomized Controlled Trial
Lead sponsor
Shenzhen Ausa Pharmed Co.,Ltd
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 31, 2013
Completion date
August 31, 2013
Enrollment
756 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension